We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Valirx Plc | LSE:VAL | London | Ordinary Share | GB00BLH13C52 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.45 | 3.40 | 3.50 | 3.45 | 3.45 | 3.45 | 49,024 | 07:40:09 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 0 | -2.37M | -0.0262 | -1.32 | 3.11M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/12/2022 08:52 | Everyone seems to think Val will set up a lab and within weeks be raking it in and the company will live happy ever after. If that were the case everyone would be doing it if it were that easy. It’s a very competitive market with leading industry players and it’s naive and negligent to think it’s some sort of golden ticket. And with Vals track record on delivery it’s odds on it will be a disaster. | francoismyname | |
15/12/2022 06:31 | Nick doesnt seem to think so. The only Rally we will see here is the 2 wheel variety with a gear stick in the middle!! | tburns | |
14/12/2022 23:43 | New lab with no placing.Val should have revenue by New Year.First time ever!Hello Santa Rally! | livedata21 | |
14/12/2022 21:33 | Hi nick. Im really not happy with what they are saying on lse about you ? They think the share price is tanking because of your sells but this is not correct. The share price is tanking because susy delay dillydashpack the third is clueless. Watch the video. She goes more red in the face when answering questions on 201. In fact more red than a baboons backside. 🤣🤣 | jasonpugh | |
14/12/2022 21:10 | Expect heavy selling tomorrow early doors . People trying to get out before Nick sells the lot. | francoismyname | |
14/12/2022 19:32 | Then the 4p placing as the cherry on the cake. | francoismyname | |
14/12/2022 19:31 | Nico smelling the coffee , only another 4% to go. Below 10p seem a certainty | francoismyname | |
14/12/2022 18:53 | See Nico has sold down again | reidy66 | |
14/12/2022 16:42 | By Friday we could buy at 10p..just a rough guess on my wish list. | baldrick1 | |
14/12/2022 13:42 | Since you mentioned Nico it looks to me like he's still offloading. Of course I may be wrong | gerry pacemaker | |
14/12/2022 13:42 | Excellent post !!!And exactly how it is. | amaretto1 | |
14/12/2022 13:38 | Great post Porky. Some people are in a hope and pray mode. At least you have spelt it out in no uncertain terms. The only point I disagree with you is the placing will be done at 4p and much sooner than you think . | francoismyname | |
14/12/2022 12:52 | Porky has an agenda. That's clear to see. Shame on the squealing pig. Trying to get investors to sell to enable him to buy cheaper. I think there's a name for people like him. I do agree that the directors buying would send out a strong signal. I think Nico raised that point and rightly so. | sooty snipes | |
14/12/2022 12:45 | You still skint then Porky. | 412069 | |
14/12/2022 11:49 | Just had the chance to watch the latest Investment brief before I go away. Frankly, the Naivety of the BOD is just breath taking as I see it. 1. Its clear from the update on the pipeline drugs that there will be zero income from these during 2023. NONE of them will be positioned to deliver revenue in the next 12 months. It will take significantly longer, period. Hence, cash burn will just continue until they need more. 2. Holding out for THX to come through for 201 is just utter nonsense. The start up hasn’t got funded in more than 12 months now. IMO there is next to zero interest in any VC, PE house or institutional investor wanting to back a bio start up when the market is flooded with significantly lower risk M&A and buy out deals that need funding that will deliver quicker returns. VAL are locked in now, if they change at this late stage its another twelve mths and outside the current cash runway. 3. A year on there is still no market provenance regarding the THX outfit, rest of the pipeline, prospectus, website anything nor are there any known examples of a previous bios invested in positioned and listed that THX or Ken has supported that have been demonstrated. This does not match with anything I have seen funded stateside. Wasted opportunity IMO. 4. I hold the opinion that as THX has got want they want without financial exposure they can simply wait until the drug is positioned has a Bio lined up and ONLY then do the deal. This is what I would do, why forward money to VAL at all? Do that when you know a deal is imminent. Best guess absolute minimum of 18mths. (9 mths to position/ 9 mths DD with potential party at best). THX have not delivered what they originally said and due to poor control by VAL they have allowed it to slip. 5. They now want to fund the rent on the lab out of savings? What? Another U-turn. The cost base has gone up significantly with recent appointments and new pipeline drugs. They have confirmed the cash runway is to end of 2023. So, we changed from buying a lab with clients with equity to renting one. What they mean is they are keeping the equity for a working capital raise instead and its us shareholders that will be paying for the lab rent. 6. Totally deluded to think they will overnight go from renting the new shiny lab and having a couple of million revenue coming in from clients to cover overheads. They must win the business from scratch, no previous history, it will take time and it will involve sales and marketing, who is doing that exactly? The business won’t fall out of the sky on them, they have to compete for it. They are not collecting the 10k pcm that THX signed up to, I dread to think how they will manage lab fees from other clients. Frankly, I am really looking forward to CENKOS next projection update so I can see exactly how they intend to get there, I will be impressed how CENKOS can spin this. The recent performance has been underwhelming. 7. They currently have 20m shares ready to go for working capital. If they issued them today, they could probably add £1.6m at 8p but they are deluding themselves. Just like the last time. Come April when the results to this December are published the exact cash burn will be confirmed and they will have 6-9mths max runway left. A raise then for working capital will be more likely back at 5p again as I don’t see a catalyst anytime soon to boost the share price They are lining themselves up yet again to be in this position. Reactive not proactive. 8. No skin in the game. I am shocked frankly that neither Kevin, Suzy nor even Stella have brought any stock, what does that tell you? It tells me they are not confident in an investment return. They have their no risk options to fall back on. If I were at VAL and I knew the pipeline drugs were going to be worth millions, THX was going to come through shortly, I would be filling my boots with stock in the open periods. Reality is they know it will take time, they know more placings are likely and wont risk their own cash to be diluted. I have this still on my radar to add but just cannot do it. I was thinking before of a buying target 7-8p but the way it is now, I can genuinely see this being left and left, zero action taken and them drift towards a capital raise at the eleventh hour again after results and it being done at further discount like 5p and them then doing a share consolidation job again. Perhaps the BOD will buy at the next placing? Anyhow, will leave now to the resident P&D crew here and when I get back in Jan take another look then. Likely review when CENKOS issue broker notes in April. Good Luck but I see no immediate reasons to Buy as it stands, this is a very slow burn imo. | porky9 | |
14/12/2022 11:48 | Support line is at 10.5p Break the support line and we are looking at back towards 5p | porky9 | |
14/12/2022 10:45 | So here we are hovering just above 10p. This is after CLX001 and the Kings tie-up was announced. Bloody ridiculous if you ask me. | sooty snipes | |
14/12/2022 10:30 | 50k sells going through at bid price. Looking like well below 10p for Xmas and then the dreaded placing taking it to 4p | francoismyname | |
14/12/2022 10:10 | There has been news news news for the past 12 years. What you want is results results results. Falling again I see | francoismyname | |
14/12/2022 10:08 | News wise very good progress being made, share price wise, very disappointing. | wulber | |
13/12/2022 17:47 | I'll definitely buy between 8-10p but not 4p(sorry franco ) | baldrick1 | |
13/12/2022 16:26 | Did I miss something or it Finished down today Next placing at 4p Cash burn continues unabated. Every time Suzy speaks price goes down. Strategy and business plan changes monthly. Nothing has ever been delivered . Time for Suzy to go. | francoismyname | |
13/12/2022 11:31 | Monkey boy P and D gang !!!'The share price is showing u all this | amaretto1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions